Stockreport

Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 [Yahoo! Finance]

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF Data presented for a new NeXT Personal feature for monitoring resistance mutations FREMONT, Calif., April 21, 2026 BUSINESS WIRE )--Personalis, Inc. (Nasdaq: PSNL), a [Read more]